BRCA1 and breast carcinoma: Women recently diagnosed with breast cancer may want to take their BRCA1/2 status into consideration for their choice of surgical treatment (i.e. breast-conserving with radiotherapy versus ipsi/contralateral mastectomy) and, in the near future, chemotherapy (i.e. PARP-inhibitors) [5-10].